New windows, same old house: an update on acute stroke management

Advanced Emergency Nursing Journal
Kyle A Weant, Stephanie N Baker

Abstract

Acute stroke is a common presentation to emergency departments and is the third leading cause of death in the United States. Despite the frequency of this event, and its substantial morbidity and mortality, few therapies exist to limit the damage from this devastating diagnosis. One pharmacotherapy for ischemic stroke that has demonstrated efficacy in this setting is tissue plasminogen activator (Activase; tPA; alteplase). Current guidelines for this agent recommend its use within the first 3 hr of the onset of stroke symptoms in patients who meet specified criteria. However, more recent data have lead to recommending the extension of this time frame to 4.5 hr after onset of symptoms in specific patient populations. Although this therapy has demonstrated efficacy in improving outcomes, its use is often complicated by complex inclusion and exclusion criteria, risk of hemorrhage, requirement for intense patient monitoring, substantial cost, and the potential for devastating medication errors.

References

Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Nov 1, 1995·Stroke; a Journal of Cerebral Circulation·G AzzimondiR D'Alessandro
Apr 1, 1997·Stroke; a Journal of Cerebral Circulation·M Fisher
Dec 4, 1998·Stroke; a Journal of Cerebral Circulation·J CastilloM Noya
Oct 8, 1999·Stroke; a Journal of Cerebral Circulation·D G DarbyS M Davis
Sep 17, 2002·Archives of Internal Medicine·Dawn M BravataLawrence M Brass
Oct 17, 2002·Emergency Medicine Clinics of North America·Joe Suyama, Todd Crocco
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Irene L KatzanUNKNOWN Cleveland Clinic Health System Stroke Quality Improvement Team
May 3, 2003·Nature Reviews. Neuroscience·Eng H LoMichael A Moskowitz
Aug 2, 2003·Stroke; a Journal of Cerebral Circulation·Tracey A BairdStephen M Davis
Jan 14, 2004·Hypertension·Larry B Goldstein
Feb 6, 2004·Stroke; a Journal of Cerebral Circulation·Perttu J Lindsberg, Risto O Roine
Feb 5, 2005·Stroke; a Journal of Cerebral Circulation·E Clarke HaleyUNKNOWN TNK in Stroke Investigators
Sep 27, 2005·Journal of Neurology·S T EngelterP A Lyrer
Oct 26, 2005·European Neurology·Chin-I ChenAndrei V Alexandrov
Apr 1, 2006·Stroke; a Journal of Cerebral Circulation·Anthony J FurlanUNKNOWN DEDAS Investigators
Sep 26, 2008·The New England Journal of Medicine·Werner HackeUNKNOWN ECASS Investigators
Feb 27, 2010·Stroke; a Journal of Cerebral Circulation·E Clarke HaleyUNKNOWN Tenecteplase in Stroke Investigators
Dec 17, 2010·Circulation·Véronique L RogerUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Jun 6, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Fei ZhouYing Xia
Jan 25, 2013·International Journal of Molecular Sciences·Ryan C TurnerJason D Huber
Jan 1, 2014·International Scholarly Research Notices·Donald J DeGraciaZhi-Feng Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Syoichiro KonoKoji Abe
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Sameer BansalPooja Khatri
Current Treatment Options in Cardiovascular Medicine
Nhu T BruceJustin A Zivin
© 2021 Meta ULC. All rights reserved